Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Affimed Announces Filing for the Opening of Insolvency Proceedings
-
Cycurion Secures $33 Million Contract Renewal to Enhance Cybersecurity for State-Level Public Higher Education Institutions
-
Atsign's NoPorts Solution Creates First "Invisible Cloud" on Amazon Web Services (AWS)
-
OneMedNet Enhances Data Discovery and Analytics with the Datavant Connect platform and Amazon Web Service (AWS) Clean Rooms
-
Atsign's NoPorts Solution Creates First "Invisible Cloud" on Amazon Web Services (AWS)
-
Royalty Pharma to Present at Upcoming Investor Conferences
-
Eneba Releases New Survey - Finds Gamers Care More About Price Than Platform
-
XRP News: Vaultro Finance Presale Moves Fast — Early Investors Eye Massive 30% Listing Gain on XRP’s Hottest DeFi Protocol
-
Golar LNG Limited Q1 2025 results presentation – Date change
-
PBGH Announces Jumbo Employers’ Top 5 Health Care Priorities
-
Delinea Begins FedRAMP High Authorization Process for Secret Server
-
VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference
-
Plotly Honored as Bronze Stevie Award Winner In 2025 American Business Awards
-
Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
-
Interim Management Statement covering Q3 2024/25
-
SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury
-
FTC Solar to Participate in Upcoming Investor Conferences
-
Lido Merger Sub, Inc. Announces Commencement of Tender Offer and Consent Solicitation for 8.875% Senior Notes due 2029 of Landsea Homes Corporation
-
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
-
VoIP-Pal Affirms Court Acceptance of Second Amended Complaint and Service upon Defendants in Federal Antitrust and RICO Lawsuit
-
Loadsmart Announces Brokerage and Managed Transportation Leader Geoff Kelley as New COO
-
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
-
IES Holdings Appoints Kelly C. Janzen to its Board of Directors
-
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters
-
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist
-
GIA GemKit Brings Gem Science to Any Classroom
-
Remedy Plan Therapeutics Raises $18 Million Financing to Accelerate Advancement of Lead Asset RPT1G into Phase 1/2 Trials
-
Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results
-
ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
-
StorONE’s NVMe Technology Chosen to Power Leading Credit Company’s Storage Needs
-
Liberty Defense has Appointed The Honorable David Kris, Former Assistant Attorney General for National Security and Deputy General Counsel and Chief Compliance Officer at Time Warner, Inc. and Founder
-
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
-
Microchip Opens Registration for its 25th Annual MASTERs Conference in Scottsdale, Arizona
-
Protara Therapeutics to Participate in Upcoming Investor Conferences
-
Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway
-
DJI Mavic 4 Pro Spins Up a Game-Changing Drone with the Mavic 4 Pro; Learn More Info at B&H
-
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
-
Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
-
Highwire Appoints Powerhouse Michael O’Brien as CEO
-
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results
-
Viasat Selected by U.S. Space Force for Phase 2 of Enterprise Space Terminal Program
-
Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
-
GrowGeneration’s MMI Announces New Luxury Mobile Package & Luggage Storage Solution Designed Exclusively for Waldorf Astoria Hotels
-
Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital
-
Silicon Motion to Attend Upcoming Investor Conferences
-
Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems
-
Reviva to Participate in the A.G.P. Healthcare Company Showcase
-
Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic Innovation
-
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
-
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025
